Dr Reddy’s gets USFDA investigation conclusion report for Srikakulam manufactruring facility in Andhra Pradesh

Overview

• Post By : Kumar Jeetendra


• Source: PTI


• Date: 08 May,2020

Medication major Dr Reddy’s Laboratories on Friday said the US wellbeing controller has shut assessment of its assembling office in Srikakulam, Andhra Pradesh.

The US Food and Drug Administration (USFDA) had given an admonition letter to the office in November, 2015, in the wake of assessing it in 2014.

“We have gotten the foundation examination report from the USFDA, for the Srikakulam office, demonstrating conclusion of the review and the investigation characterization of this office,” Dr Reddy’s Laboratories said in an administrative documenting.

With this, all offices under notice letter are presently decided as ‘intentional activity showed’, the medication major said.